Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Oct 21, 2009; 15(39): 4865-4876
Published online Oct 21, 2009. doi: 10.3748/wjg.15.4865
Published online Oct 21, 2009. doi: 10.3748/wjg.15.4865
Initial change | Intermediate effects | Consequences |
Increased bioactivation (microsomal CYP 450s) | Higher amount of toxic metabolites | Consumption of antioxidants |
Increased release of ROS | Lipid peroxidation | |
Mitochondrial dysfunction | Decreased energy production (ATP) and cytochrome c content | Over-expression of uncoupling protein 2 |
Increased Ca2+ efflux | ||
Increased release of ROS and NO derivatives | Protein oxidation and nitration | |
Pores opening and increased membrane permeability | Expression of FAS ligands | |
Calpain activation and protein cleavage | ||
Impaired intracellular signaling and trafficking | Alterations of nuclear receptors and sensors | Defective transcription of repair mechanisms |
Increased DNA fragmentation rate | ||
Activation of non-parenchymal cells (Kupffer cells) and enzymes | Increased release of transforming growth factor-β1, p53, TNF-α | Inflammation and pro-oxidant attack |
Increased NADPH oxidase activity |
- Citation: Grattagliano I, Bonfrate L, Diogo CV, Wang HH, Wang DQ, Portincasa P. Biochemical mechanisms in drug-induced liver injury: Certainties and doubts. World J Gastroenterol 2009; 15(39): 4865-4876
- URL: https://www.wjgnet.com/1007-9327/full/v15/i39/4865.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.4865